HbA1c Assay by Randox Laboratories Ltd.

The concentration of HbA1c in the blood of diabetic patients increases with rising blood glucose levels and is representative of the mean blood glucose level over the preceding six to eight weeks. HbA1c can therefore be described as a long term indicator of diabetic control unlike blood glucose which is only a short term indicator of diabetic control. It is therefore a more reliable indicator of glycaemic control than blood glucose. Determination of HbA1c is of great importance in the long term care of the diabetic patient and as such it is recommended that HbA1c levels are monitored every three to four months.

Randox HbA1c
Sample type – Suitable for use with whole blood samples
Immunoassay method – The Randox assay utilises an immunoassay method making it simple and quick to perform.
Standardisation – The Randox HbA1c calibrator set is referenced to the Drabkin’s method for Total Haemoglobin and an HPLC method for HbA1c.
Liquid ready to use reagents – For ease of use and convenience
Excellent stability – All reagents are stable to expiry date when stored at +2-8⁰C or 30 days on board the analyser at approximately 10°C.
Combined kit – Intended for the determination of both HbA1c and Total
Haemoglobin, the reported HbA1c result is calculated as a percentage of the total haemoglobin concentration.
Haemoglobin denaturant – Supplied with the kit